A Phase 2, Multicenter Study of Nevanimibe for the Treatment of Congenital Adrenal Hyperplasia

Article

Abstract: Context: Patients with classic congenital adrenal hyperplasia (CAH) often require supraphysiologic g

Palabras claves:

adrenal hypertrophy, ATR-101, Clinical trial, Congenital adrenal hyperplasia, nevanimibe

Autores:

Chang A.Y., El-Maouche D., Joyal E.G., Lin V.H., Merke D.P., Mohideen P., Plaunt M.R., Richard J. Auchus, Turcu A.F., Vogiatzi M.G., Weintraub L.

Fuentes:

scopus